Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

51.23
Delayed Data
As of Aug 26
 +1.26 / +2.52%
Today’s Change
35.37
Today|||52-Week Range
143.08
-20.23%
Year-to-Date
No recent news for bluebird bio Inc.

Today’s Trading

Previous close49.97
Today’s open50.17
Day’s range50.00 - 51.90
Volume899,764
Average volume (3 months)937,003
Market cap$1.9B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-162.84%
Earnings growth (this year)-28.43%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)-44.62%
P/E ratioNM
Price/Sales158.14
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+1.02+1.95%
NVAXNovavax Inc+0.31+4.51%
ARIAARIAD Pharmaceutical...+0.05+0.49%
EXASExact Sciences Corp+0.14+0.73%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$1.51
Annual revenue (last year)$14.1M
Annual profit (last year)-$166.8M
Net profit margin-1,184.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Financial &
Strategy Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs